Abstract
THE recent communications by Dowben1 and Tubis et al. 2 regarding possible therapeutic procedures for mice with a genetically determined form of myopathy3 have prompted this preliminary communication commenting on some problems relating to longevity in animals with this defect.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Dowben, R. M., Nature, 184, 1966 (1959).
Tubis, M., Baker, N., and Bland, W., J. Nutrition, 68, 595 (1959).
Michelson, A. M., Russell, E. S., and Harman, P. J., Proc. U.S. Nat. Acad. Sci., 41, 1079 (1955).
Berneske, G. M., Butson, A. R. C., Gauld, E. N., and Levy, D., Canad. Med. Assoc. J., 82, 418 (1960).
Coleman, D. L., Thirtieth Ann. Rep. Roscoe B. Jackson Memorial Lab., 10 (1959).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
MILLER, J., WOOD, A. & GIBSON, W. Longevity in Mice with a genetically determined Muscular Dystrophy. Nature 190, 552 (1961). https://doi.org/10.1038/190552a0
Issue date:
DOI: https://doi.org/10.1038/190552a0